Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults

NCT04735913 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT04735913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04735913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
Lead sponsor
Zhongnan Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
May 5, 2020
Completion date
July 1, 2022
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abiraterone acetate, gene polymorphism, metabolic analysis, pharmacokinetic, plasma concentration